Literature DB >> 11550084

Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death.

U S Gaipl1, S Kuenkele, R E Voll, T D Beyer, W Kolowos, P Heyder, J R Kalden, M Herrmann.   

Abstract

The phagocytosis of dying cells is an integral feature of apoptosis and necrosis. There are many receptors involved in recognition of dying cells, however, the molecular mechanisms of the scavenging process remain elusive. The activation by necrotic cells of complement is well established, however, the importance of complement in the scavenging process of apoptotic cells was just recently described. Here we report that the complement components C3 and C4 immediately bound to necrotic cells. The binding of complement was much higher for lymphocytes compared to granulocytes. In case of apoptotic cell death complement binding was a rather late event, which in lymphocytes was preceded by secondary necrosis. Taken together complement binding is an immediate early feature of necrosis and a rather late event during apoptotic cell death. We conclude that complement may serve as an opsonin for fragments of apoptotic cells that have escaped regular scavenging mechanisms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11550084     DOI: 10.1038/sj.cdd.4400826

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  46 in total

1.  Specific binding of an antigen-antibody complex to apoptotic human neutrophils.

Authors:  Simon P Hart; Caroline Jackson; L Maximillian Kremmel; Mary S McNeill; Hubertus Jersmann; Karen M Alexander; James A Ross; Ian Dransfield
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 2.  Impaired clearance of apoptotic cells in systemic lupus erythematosus: challenge of T and B cell tolerance.

Authors:  Susanne Kuenkele; Thomas D Beyer; Reinhard E Voll; Joachim R Kalden; Martin Herrmann
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

3.  Extranuclear detection of histones and nucleosomes in activated human lymphoblasts as an early event in apoptosis.

Authors:  C Gabler; N Blank; T Hieronymus; M Schiller; J H M Berden; J R Kalden; H-M Lorenz
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

4.  Molecular MRI of acute necrosis with a novel DNA-binding gadolinium chelate: kinetics of cell death and clearance in infarcted myocardium.

Authors:  Shuning Huang; Howard H Chen; Hushan Yuan; Guangping Dai; Daniel T Schuhle; Choukri Mekkaoui; Soeun Ngoy; Ronglih Liao; Peter Caravan; Lee Josephson; David E Sosnovik
Journal:  Circ Cardiovasc Imaging       Date:  2011-08-11       Impact factor: 7.792

Review 5.  Defects in the disposal of dying cells lead to autoimmunity.

Authors:  Udo S Gaipl; Sandra Franz; Reinhard E Voll; Ahmed Sheriff; Joachim R Kalden; Martin Herrmann
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

Review 6.  The role of the complement system in innate immunity.

Authors:  Horea Rus; Cornelia Cudrici; Florin Niculescu
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

7.  Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo.

Authors:  Jie Tian; Zhili Xu; Jeffrey S Smith; Sean E Hofherr; Michael A Barry; Andrew P Byrnes
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

8.  The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells.

Authors:  Jin-Jung Choi; Charles F Reich; David S Pisetsky
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

9.  SIGN-R1, a C-type lectin, enhances apoptotic cell clearance through the complement deposition pathway by interacting with C1q in the spleen.

Authors:  M G Prabagar; Y Do; S Ryu; J-Y Park; H-J Choi; W-S Choi; T J Yun; J Moon; I-S Choi; K Ko; K Ko; C Young Shin; C Cheong; Y-S Kang
Journal:  Cell Death Differ       Date:  2012-12-14       Impact factor: 15.828

Review 10.  Antibodies against C1q in patients with systemic lupus erythematosus.

Authors:  Marten Trendelenburg
Journal:  Springer Semin Immunopathol       Date:  2005-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.